Maxcyte (MXCT) Cash from Financing Activities (2020 - 2026)
Maxcyte (MXCT) posted quarterly Cash from Financing Activities of $5000.0 for Q1 2026, down 98.69% year-over-year from $383000.0 in Q1 2025, and down 95.24% quarter-over-quarter from $105000.0 in Q4 2025.
Maxcyte (MXCT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Cash from Financing Activities for 7 consecutive years, with $5000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 98.69% year-over-year to $5000.0; the TTM figure through Mar 2026 stood at $278000.0 (down 83.99% YoY), while the FY2025 annual figure was $656000.0, down 68.09% from the prior year.
- Cash from Financing Activities eased to $5000.0 in Q1 2026 per MXCT's latest filing, from $105000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.5 million in Q1 2023 and bottomed at $5000.0 in Q1 2026.
- Historically, Cash from Financing Activities has averaged $455764.7 across 5 years, with a median of $383000.0 in 2025.
- On a YoY basis, Cash from Financing Activities climbed as much as 1087.96% in 2022 and fell as far as 99.76% in 2022.
- Maxcyte's Cash from Financing Activities stood at $1.2 million in 2022, then plunged by 59.77% to $493000.0 in 2023, then declined by 16.43% to $412000.0 in 2024, then tumbled by 74.51% to $105000.0 in 2025, then slumped by 95.24% to $5000.0 in 2026.
- Business Quant data shows MXCT's Cash from Financing Activities at $5000.0 in Q1 2026, $105000.0 in Q4 2025, and $14000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Maxcyte | 149.55 Mn | 149.55 Mn | 5.60 Mn | -1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.42 Mn |
| Jun 30, 2026 | -1.42 Mn |
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Jun 30, 2024 | 713,000.00 |
| Jun 30, 2024 | 713,000.00 |
| Mar 31, 2024 | 703,000.00 |
| Mar 31, 2024 | 703,000.00 |